Industry News
Pharmaceutical Industry News
GlaxoSmithKline and Vir’s sotrovimab stands up to omicron despite other COVID antibodies falling short
GlaxoSmithKline and Vir's sotrovimab stands up to omicron despite other COVID antibodies falling short kdunleavy Tue, 12/07/2021 - 10:40
Orexo unveils nasal EpiPen rival, sets sights on 2022 clinical trial
Orexo unveils nasal EpiPen rival, sets sights on 2022 clinical trial ntaylor Tue, 12/07/2021 - 09:58
Orexo unveils nasal EpiPen rival, sets sights on 2022 clinical trial
Orexo unveils nasal EpiPen rival, sets sights on 2022 clinical trial ntaylor Tue, 12/07/2021 - 09:58
Alvotech, battling AbbVie over its Humira biosim, raises $450M and tees up Nasdaq debut
Alvotech, battling AbbVie over its Humira biosim, raises $450M and tees up Nasdaq debut fkansteiner Tue, 12/07/2021 - 09:37
Alvotech, battling AbbVie over its Humira biosim, raises $450M and tees up Nasdaq debut
Alvotech, battling AbbVie over its Humira biosim, raises $450M and tees up Nasdaq debut fkansteiner Tue, 12/07/2021 - 09:37
PureTech’s oral drug delivery work spawns clinical-phase challenger to Sage in depression
PureTech's oral drug delivery work spawns clinical-phase challenger to Sage in depression ntaylor Tue, 12/07/2021 - 09:28
PureTech’s oral drug delivery work spawns clinical-phase challenger to Sage in depression
PureTech's oral drug delivery work spawns clinical-phase challenger to Sage in depression ntaylor Tue, 12/07/2021 - 09:28
Sixfold bags VC funding to expand RNA delivery beyond the liver
Sixfold bags VC funding to expand RNA delivery beyond the liver ntaylor Tue, 12/07/2021 - 08:42
Sixfold bags VC funding to expand RNA delivery beyond the liver
Sixfold bags VC funding to expand RNA delivery beyond the liver ntaylor Tue, 12/07/2021 - 08:42
Visus closes in on AbbVie with midphase data on long-sightedness eye drop
Visus closes in on AbbVie with midphase data on long-sightedness eye drop ntaylor Tue, 12/07/2021 - 08:34
Visus closes in on AbbVie with midphase data on long-sightedness eye drop
Visus closes in on AbbVie with midphase data on long-sightedness eye drop ntaylor Tue, 12/07/2021 - 08:34
New Covid Antiviral Pills Offer Hope as Omicron Looms
Merck and Pfizer will soon debut prescription pills to treat Covid-19. And more drugs are on the way.
Biden Focuses on How Spending Bill Would Lower Drug Costs
President Biden emphasized how the bill would lower prescription drug costs, an issue his administration hopes will build support for the broader package.
Biden Touts Legislation to Reform Prescription Drug Prices
President Biden presented a key provision from his Build Back Better bill that would take steps to combat the high costs of prescription drugs.
AbbVie’s Rinvoq notches Crohn’s disease win amid classwide JAK safety concerns
AbbVie's Rinvoq notches Crohn's disease win amid classwide JAK safety concerns fkansteiner Mon, 12/06/2021 - 13:36
Merck taps Thermo Fisher to manufacture COVID pill in Canada for global rollout push
Merck taps Thermo Fisher to manufacture COVID pill in Canada for global rollout push jkeenan Mon, 12/06/2021 - 11:11
Lawmakers to unveil findings on long-running drug pricing probe and discuss reforms
Lawmakers to unveil findings on long-running drug pricing probe and discuss reforms kdunleavy Mon, 12/06/2021 - 10:47
AbbVie’s Rinvoq, Pfizer’s Xeljanz and Lilly’s Olumiant slapped with new FDA warnings amid JAK safety crackdown
AbbVie's Rinvoq, Pfizer's Xeljanz and Lilly's Olumiant slapped with new FDA warnings amid JAK safety crackdown aliu Mon, 12/06/2021 - 10:26
Merck’s Hilleman Laboratories tees up $58M investment at new Singapore vaccine hub
Merck's Hilleman Laboratories tees up $58M investment at new Singapore vaccine hub fkansteiner Mon, 12/06/2021 - 10:04
Gilead recalls 2 lots of COVID-19 drug Veklury after finding glass particulates in vials
Gilead recalls 2 lots of COVID-19 drug Veklury after finding glass particulates in vials fkansteiner Mon, 12/06/2021 - 08:43